It is trying to treat a devastating lifelong disease by fixing it at its source. We are able to fix the actual genetic ...

Because gene SDR42E1 is involved in vitamin D metabolism, scientists could also target it in any of the many diseases.

Cells called astrocytes are about as abundant in the brain as neurons, but scientists have spent much less time figuring out ...

A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune ...

In the study, published in the journal Frontiers in Endocrinology, the researchers used CRISPR/Cas9 gene editing to transform ...

Danaher, a United States-headquartered life sciences conglomerate, announced a strategic partnership in Shanghai on Monday between its operating company Cytiva and CorrectSequence Therapeutics, a ...

CRISPR construct to genetically ablate the GABA transporter GAT3 in the mouse visual cortex, with effects on population-level neuronal activity. This work is important, as it sheds light on how GAT3 ...

Iowa State engineers, left to right, Connor Thorpe and Shan Jiang helped invent the "Flow Guiding Barrel," which improves gene gun performance for the ...

CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel Prize-winning CRISPR/Cas9 gene editing technology. While CRSP is the first and ...

A cross-sector group of concerned citizens is urging the Government to reconsider its position on the proposed Gene Technology Bill.

Researchers create a one-time genome editing introducing a GLP-1 receptor agonist, resulting in long-term appetite suppression, weight loss, and blood sugar control in mice.